» Articles » PMID: 8598934

Organ Targeting in Vivo Using Phage Display Peptide Libraries

Overview
Journal Nature
Specialty Science
Date 1996 Mar 28
PMID 8598934
Citations 350
Authors
Affiliations
Soon will be listed here.
Abstract

Preferential homing of tumour cells and leukocytes to specific organs indicates that tissues carry unique marker molecules accessible to circulating cells. Organ-selective address molecules on endothelial surfaces have been identified for lymphocyte homing to various lymphoid organs and to tissues undergoing inflammation, and an endothelial marker responsible for tumour homing to the lungs has also been identified. Here we report a new approach to studying organ-selective targeting based on in vivo screening of random peptide sequences. Peptides capable of mediating selective localization of phage to brain and kidney blood vessels were identified, and showed up to 13-fold selectivity for these organs. One of the peptides displayed by the brain-localizing phage was synthesized and shown to specifically inhibit the localization of the homologous phage into the brain. When coated onto glutaraldehyde-fixed red blood cells, the peptide caused selective localization of intravenously injected cells into the brain. These peptide sequences represent the first step towards identifying selective endothelial markers, which may be useful in targeting cells, drugs and genes into selected tissues.

Citing Articles

Screening of homing and tissue-penetrating peptides by microdialysis and in vivo phage display.

Pemmari T, Prince S, Wiss N, Koiv K, May U, Molder T Life Sci Alliance. 2025; 8(5).

PMID: 39933917 PMC: 11814485. DOI: 10.26508/lsa.202201490.


Unveiling the new chapter in nanobody engineering: advances in traditional construction and AI-driven optimization.

Liu J, Wu L, Xie A, Liu W, He Z, Wan Y J Nanobiotechnology. 2025; 23(1):87.

PMID: 39915791 PMC: 11800653. DOI: 10.1186/s12951-025-03169-5.


Microenvironmental determinants of endothelial cell heterogeneity.

Gomez-Salinero J, Redmond D, Rafii S Nat Rev Mol Cell Biol. 2025; .

PMID: 39875728 DOI: 10.1038/s41580-024-00825-w.


Targeted therapeutic strategies for the kidney.

Yuan F, Lerman L Expert Opin Ther Targets. 2024; 28(11):979-989.

PMID: 39491501 PMC: 11617265. DOI: 10.1080/14728222.2024.2421756.


Enhanced docetaxel therapeutic effect using dual targeted SRL-2 and TA1 aptamer conjugated micelles in inhibition Balb/c mice breast cancer model.

Taghipour Y, Zarebkohan A, Salehi R, Talebi M, Rahbarghazi R, Khordadmehr M Sci Rep. 2024; 14(1):24603.

PMID: 39427007 PMC: 11490543. DOI: 10.1038/s41598-024-75042-8.